Genomic Precision

 A SeraCare blog focused on precision medicine and advanced clinical diagnostics

You can’t validate everything… can you?

Posted by Sam Blier on Sep 21, 2017 10:00:00 AM

“Is there a limit on the type of mutations we would need to validate given that the cost per validation is high?”

This question was recently posted to a panel of clinical genomics experts that we convened for a webinar hosted by GenomeWeb (you can download a full report on the entire series here). Panelists Girish Putcha, MD, PhD, Director of Laboratory Science, Palmetto GBA; Roger Klein, MD, Principal, JD Consulting; and Elaine Lyon, PhD, Medical Director, Molecular Genetics and Genomics, ARUP Laboratories, weighed in with thoughtful responses to a query that’s on the minds of many clinical laboratorians.

 

Read More

Topics: variants, Clinical Genetic Testing, performance-based metrics, synthethic controls, methods-based validation

 
 

Subscribe for Updates

Categories

see all